🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate itacitinib or placebo in combinati...
Status
Completed
Location
University of California, San Diego (UCSD) - Moores Cancer Center
Start Date
2017-07-19
Trial ID
NCT03139604
Treatments Being Tested
The purpose of this study is to determine if Itacitinib in combination with...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02355431
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of itacitini...
Status
Terminated
Location
University of Arizona Cancer Center - Out Pt.
Start Date
2019-01-17
Trial ID
NCT03584516
Treatments Being Tested
This is a study evaluating a 28-day course followed by a 56-day course of i...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01626573
Treatments Being Tested
"The purpose of this study is to assess the safety and efficacy of oral adm...
Status
Completed
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2020-02-07
Trial ID
NCT04071366
Treatments Being Tested
The primary objectives of this study were to evaluate the safety and tolera...
Status
Terminated
Location
Multiple Locations
Start Date
2014-09-24
Trial ID
NCT02257619
Treatments Being Tested
The purpose of this study is to determine whether itacitinib is safe and ef...
Status
Recruiting
Location
CH Amiens
Start Date
2023-02-02
Trial ID
NCT04789850
Treatments Being Tested
This is a study of itacitinib in patients with chronic plaque psoriasis. Th...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01634087
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of itaciti...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-09-20
Trial ID
NCT03627052
Treatments Being Tested